首頁 > 市場調查報告書 > 製藥

市場調查報告書

商品編碼

1488251

骨髓抽吸濃縮物市場 - 副產品（系統、配件）、應用（骨科手術、傷口癒合、血液癌、週邊血管疾病、疼痛管理、血液癌）、最終用途（醫院） - 全球預測 2024 - 2032 年

Bone Marrow Aspirate Concentrates Market - By Product (Systems, Accessories), Application (Orthopaedic Surgery, Wound Healing, Blood Cancer, Peripheral Vascular Diseases, Pain Management, Blood Cancer), End-use (Hospitals) - Global Forecast 2024 - 2032

出版日期: 2024年03月18日 | 出版商:

Global Market Insights Inc. | 英文 120 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

在該領域研發進步的推動下，2024 年至 2032 年間，全球骨髓抽吸濃縮物市場規模的複合年成長率將超過 5.4%。 BMAC 源自於患者的骨髓，含有間質幹細胞和生長因子，使其成為各種骨科疾病和退化性疾病的有前途的治療選擇。例如，2021 年9 月，根據《美國運動醫學雜誌》發表的研究，在骨髓抽吸濃縮物注射的幫助下，在改善膝骨關節炎(OA) 的疼痛和患者報告的結果方面取得了有希望的結果。

隨著研究發現 BMAC 的新應用和治療益處，醫療保健提供者和患者的興趣日益濃厚。此外，探索 BMAC 在治療骨關節炎和骨不連骨折等挑戰性疾病方面的功效的臨床試驗進一步刺激了市場需求。 BMAC 領域的研究和開發日益受到關注，突顯了其徹底改變再生醫學和解決未滿足的醫療需求的潛力。

整個骨髓抽吸濃縮物產業根據產品、應用、最終用途和地區進行分類。

骨髓抽吸濃縮物配件部分將在 2024 年至 2032 年期間經歷嚴格的發展。這些配件包括製備和管理 BMAC 注射液所需的專用套件、離心機和處理系統。隨著 BMAC 手術在骨科和再生醫學實踐中越來越廣泛採用，對這些配件的需求也相應增加。醫療機構和提供者尋求高效可靠的工具來最佳化 BMAC 的提取和應用，從而導致市場需求增加。這一趨勢強調了配件在促進醫療中有效利用骨髓抽吸濃縮物方面的不可或缺的作用。

傷口癒合領域的骨髓抽吸濃縮物市場佔有率將在 2024 年至 2032 年實現顯著的複合年成長率。其應用範圍從慢性傷口到急性損傷，為具有挑戰性傷口的患者提供了一個有前途的替代方案。隨著醫療保健提供者越來越認知到 BMAC 在傷口管理方面的優勢，對 BMAC 產品的需求不斷增加。這項需求凸顯了 BMAC 等創新再生療法在解決傷口癒合和改善患者預後方面日益重要的重要性。

歐洲骨髓抽吸濃縮物市場將在2024 年至2032 年呈現出值得稱讚的複合年成長率。需求。 BMAC 具有促進組織修復和再生的能力，引起了醫療保健提供者和患者的極大興趣。此外，歐洲市場有利的監管環境和健全的醫療基礎設施促進了 BMAC 程序的採用。因此，整個歐洲對 BMAC 產品和服務的需求顯著增加，反映出該地區對再生醫學的日益關注。

產業生態系統分析
產業影響力
- 成長動力
  - 骨科疾病盛行率上升
  - 老年人口不斷增加
  - 擴大BMAC的應用範圍
- 產業陷阱與挑戰
  - 治療失敗率高
  - 與手術相關的高成本
成長潛力分析
監管環境
技術景觀
波特的分析
PESTEL分析
未來市場趨勢

第 4 章：競爭格局

介紹
公司矩陣分析
公司市佔率分析
競爭定位矩陣

第 5 章：市場估計與預測：按產品分類，2018 年 - 2032 年

主要趨勢
骨髓抽吸濃縮系統
骨髓抽吸濃縮配件

第 6 章：市場估計與預測：按應用分類，2018 年 - 2032 年

主要趨勢
骨科手術
傷口癒合
周圍血管疾病
疼痛管理
血癌
其他應用

第 7 章：市場估計與預測：按最終用途，2018 - 2032 年

主要趨勢
醫院和診所
製藥和生物技術公司
CRO 和 CMO
學術及研究機構
其他最終用戶

第 8 章：市場估計與預測：按地區分類，2018 年 - 2032 年

主要趨勢
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 英國
- 法國
- 西班牙
- 義大利
- 歐洲其他地區
亞太地區
- 日本
- 中國
- 印度
- 澳洲
- 韓國
- 亞太地區其他地區
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 拉丁美洲其他地區
中東和非洲
- 沙烏地阿拉伯
- 南非
- 阿拉伯聯合大公國
- 中東和非洲其他地區

第 9 章：公司簡介

Arthrex, Inc.
Aspire Medical Innovation
EmCyte Corporation
Globus Medical, Inc.
Isto Biologics
MED & CARE - Innovative Solutions
Ranfac Corporation
Royal Biologics
Scopio Labs
Stryker Corporation
Terumo Corporation
Thermogenesis Holdings, Inc.
Zimmer Biomet Holdings, Inc.

簡介目錄

Product Code: 8565

Global Bone Marrow Aspirate Concentrates Market Size will witness over 5.4% CAGR between 2024 and 2032, propelled by advancements in research and development within the field. BMAC, derived from a patient's bone marrow, contains mesenchymal stem cells and growth factors, making it a promising treatment option for various orthopedic conditions and degenerative diseases. For instance, in September 2021, according to research published in the American Journal of Sports Medicine, there were promising results in improving both pain and patient-reported outcomes in knee osteoarthritis (OA) with the help of bone marrow aspirate concentrate injections.

As research uncovers new applications and therapeutic benefits of BMAC, there is growing interest from healthcare providers and patients alike. In addition, clinical trials exploring the efficacy of BMAC in treating challenging conditions, such as osteoarthritis and non-union fractures, further fuel market demand. This rising focus on research and development in the BMAC field underscores its potential to revolutionize regenerative medicine and address unmet medical needs.

The overall Bone Marrow Aspirate Concentrates Industry is classified based on the product, application, end-use, and region.

The bone marrow aspirate concentrates accessories segment will undergo rigorous development from 2024 to 2032. These accessories include specialized kits, centrifuges, and processing systems required for the preparation and administration of BMAC injections. As BMAC procedures become more widely adopted in orthopedic and regenerative medicine practices, the demand for these accessories rises accordingly. Healthcare facilities and providers seek efficient and reliable tools to optimize the extraction and application of BMAC, leading to increased demand in the market. This trend underscores the integral role of accessories in facilitating the effective utilization of bone marrow aspirate concentrates in medical treatments.

The bone marrow aspirate concentrates market share from the wound healing segment will register a notable CAGR from 2024 to 2032. BMAC, rich in mesenchymal stem cells and growth factors, promotes tissue regeneration and accelerates the wound healing process. Its applications range from chronic wounds to acute injuries, offering a promising alternative for patients with challenging wounds. As healthcare providers increasingly recognize the benefits of BMAC in wound management, the demand for BMAC products rises. This demand underscores the growing importance of innovative regenerative therapies like BMAC in addressing wound healing and improving patient outcomes.

Europe bone marrow aspirate concentrates market will showcase a commendable CAGR from 2024 to 2032. Europe's aging population, coupled with a rising prevalence of orthopedic conditions and degenerative diseases, has propelled the need for effective regenerative treatments. BMAC, with its ability to promote tissue repair and regeneration, has garnered significant interest among healthcare providers and patients alike. Moreover, the European market's favorable regulatory environment and robust healthcare infrastructure have fostered the adoption of BMAC procedures. As a result, there is a notable increase in demand for BMAC products and services across Europe, reflecting the region's growing focus on regenerative medicine.

Chapter 1 Methodology & Scope

1.1 Market scope & definition
1.2 Base estimates & calculations
1.3 Data collection
1.4 Forecast parameters
1.5 Data sources
- 1.5.1 Primary
- 1.5.2 Secondary
  - 1.5.2.1 Paid sources
  - 1.5.2.2 Public sources

Chapter 2 Executive Summary

2.1 Industry 360 degree synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Rising prevalence of orthopedic disorders
  - 3.2.1.2 Growing geriatric population
  - 3.2.1.3 Widening applications of BMAC
- 3.2.2 Industry pitfalls & challenges
  - 3.2.2.1 High failure rate of treatment
  - 3.2.2.2 High cost associated with the procedure
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Technological landscape
3.6 Porter's analysis
- 3.6.1 Supplier power
- 3.6.2 Buyer power
- 3.6.3 Threat of new entrants
- 3.6.4 Threat of substitutes
- 3.6.5 Industry rivalry
3.7 PESTEL analysis
3.8 Future market trends

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company matrix analysis
4.3 Company market share analysis
4.4 Competitive positioning matrix

Chapter 5 Market Estimates and Forecast, By Product, 2018 - 2032 ($ Mn)

5.1 Key trends
5.2 Bone marrow aspirate concentrates systems
5.3 Bone marrow aspirate concentrates accessories

Chapter 6 Market Estimates and Forecast, By Application, 2018 - 2032 ($ Mn)

6.1 Key trends
6.2 Orthopedic surgery
6.3 Wound healing
6.4 Peripheral vascular diseases
6.5 Pain management
6.6 Blood cancer
6.7 Other applications

Chapter 7 Market Estimates and Forecast, By End-Use, 2018 - 2032 ($ Mn)

7.1 Key trends
7.2 Hospitals & clinics
7.3 Pharmaceutical & biotechnology companies
7.4 CROs and CMOs
7.5 Academic & research institutes
7.6 Other end-users

Chapter 8 Market Estimates and Forecast, By Region, 2018 - 2032 ($ Mn)

8.1 Key trends
8.2 North America
- 8.2.1 U.S.
- 8.2.2 Canada
8.3 Europe
- 8.3.1 Germany
- 8.3.2 UK
- 8.3.3 France
- 8.3.4 Spain
- 8.3.5 Italy
- 8.3.6 Rest of Europe
8.4 Asia Pacific
- 8.4.1 Japan
- 8.4.2 China
- 8.4.3 India
- 8.4.4 Australia
- 8.4.5 South Korea
- 8.4.6 Rest of Asia Pacific
8.5 Latin America
- 8.5.1 Brazil
- 8.5.2 Mexico
- 8.5.3 Argentina
- 8.5.4 Rest of Latin America
8.6 Middle East and Africa
- 8.6.1 Saudi Arabia
- 8.6.2 South Africa
- 8.6.3 UAE
- 8.6.4 Rest of Middle East and Africa